Streetbeat News

Analyst Ratings

SITE

Loop Capital analyst Jeffrey Stevenson has downgraded SiteOne Landscape Supply (NYSE:SITE) from Buy to Hold, indicating a change in the firm's outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:22 pm

PLTR

The weekend's top stories included North Korea's missile deal with Russia, Mike Pence's stance against banning Trump from the 2024 ballot, public opinion favoring Trump's candidacy, Cathie Wood's ARK Invest increasing its stake in Palantir Technologies (NYSE:PLTR) despite analyst downgrades, and anticipation for the decision on the U.S.'s first Bitcoin ETF. ARK Invest's ETFs purchased additional shares of Palantir.

Portfolio Pulse from Benzinga Neuro

January 08, 2024 | 2:22 pm

CP

Susquehanna analyst Bascome Majors has downgraded Canadian Pacific Kansas (NYSE:CP) from Positive to Neutral, indicating a change in the firm's outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:21 pm

ZION

Compass Point analyst David Rochester has downgraded Zions Bancorp (NASDAQ:ZION) from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:17 pm

FSLY

RBC Capital analyst Rishi Jaluria has upgraded Fastly (NYSE:FSLY) from Underperform to Sector Perform and increased the price target from $12 to $18.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:14 pm

CVX

Jefferies analyst Lloyd Byrne has upgraded Chevron (NYSE:CVX) from Hold to Buy and set a price target of $184.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:09 pm

CNM

Citigroup analyst Anthony Pettinari has upgraded Core & Main (NYSE:CNM) from Neutral to Buy and increased the price target from $38 to $48. This upgrade reflects a positive outlook on CNM's stock, suggesting potential growth and a higher valuation than previously estimated.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:07 pm

EFX

B of A Securities analyst Heather Balsky upgraded Equifax (NYSE:EFX) from Underperform to Buy and increased the price target from $164 to $300, indicating a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:04 pm

AGL

Agilon Health (NYSE:AGL) received mixed ratings from 10 financial analysts, with a shift towards more bearish sentiment over the past three months. The average 12-month price target is now $18.3, down from $24.75, with a high estimate of $28.00 and a low of $9.00. Analysts from firms including Truist Securities, JP Morgan, JMP Securities, Deutsche Bank, Benchmark, Wells Fargo, Goldman Sachs, and RBC Capital have adjusted their ratings and price targets. Agilon Health's financial performance shows strong revenue growth but below-average profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 2:01 pm

FDX

Five analysts have recently updated their ratings on FedEx (NYSE:FDX), with a mix of bullish and neutral stances. The average 12-month price target is now $304.00, down from the previous $315.25. Analysts from Melius Research, Stephens & Co., Raymond James, Barclays, and JP Morgan have adjusted their price targets, with four lowering their estimates and one announcing a new 'Buy' rating. FedEx's financials show a slight revenue decline, strong net margin, ROE, and ROA, and a healthy debt-to-equity ratio. These updates may influence investors' perceptions of FedEx's stock performance in the short term.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 2:00 pm